Cargando…

When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis

Glucocorticoid-induced osteoporosis (GIOP) leads to fractures in up to 40% of patients with chronic glucocorticoid (GC) therapy when left untreated. GCs rapidly increase fracture risk, and thus many patients with anticipated chronic GC exposures should start anti-osteoporosis pharmacotherapy to prev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayes, Kaleen N., Baschant, Ulrike, Hauser, Barbara, Burden, Andrea M., Winter, Elizabeth M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715727/ https://www.ncbi.nlm.nih.gov/pubmed/34975756 http://dx.doi.org/10.3389/fendo.2021.782118

Ejemplares similares

Corrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
por: Hayes, Kaleen N., et al.
Publicado: (2022)

Editorial: Glucocorticoid and bone: Friend or foe
por: Baschant, Ulrike, et al.
Publicado: (2022)

Comment on: Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study
por: Hayes, Kaleen N, et al.
Publicado: (2022)

Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes
por: Gado, Manuel, et al.
Publicado: (2022)

Antiosteoporosis and bone protective effect of dieckol against glucocorticoid-induced osteoporosis in rats
por: Wang, Hao, et al.
Publicado: (2022)

Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making
por: Hayes, Kaleen N., et al.
Publicado: (2021)

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club
por: Laurent, Michaël R., et al.
Publicado: (2022)

The Use of Herbal Medicines for the Prevention of Glucocorticoid-Induced Osteoporosis
por: Zhang, Leiming, et al.
Publicado: (2021)

Disturbed bone marrow adiposity in patients with Cushing’s syndrome and glucocorticoid- and postmenopausal- induced osteoporosis
por: Sørensen, Nina N., et al.
Publicado: (2023)

Glucocorticoid-Induced Osteoporosis: Why Kids Are Different
por: Ward, Leanne M.
Publicado: (2020)

The Impact of High Dose Glucocorticoids on Bone Health and Fracture Risk in Systemic Vasculitides
por: Box, Christopher David, et al.
Publicado: (2022)

When to start and when to stop antifibrotic therapies
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2017)

Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans
por: Thiele, Sylvia, et al.
Publicado: (2019)

Glucocorticoid-Induced Osteoporosis – A Disorder of Mesenchymal Stromal Cells?
por: Hardy, Rowan, et al.
Publicado: (2011)

Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit
por: Lee, J.J.X., et al.
Publicado: (2021)

A bibliometric and visualization analysis of glucocorticoid-induced osteoporosis research from 2012 to 2021
por: Jiang, Buchan, et al.
Publicado: (2022)

Distinct Glucocorticoid Receptor Actions in Bone Homeostasis and Bone Diseases
por: Lee, Sooyeon, et al.
Publicado: (2022)

Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe
por: Martin, Claire S., et al.
Publicado: (2021)

Proliferation/Quiescence: When to start? Where to stop? What to stock?
por: Daignan-Fornier, Bertrand, et al.
Publicado: (2011)

When it starts in the skin and goes to the lungs, where does it stop?
por: Catarino Ferro, Ana Rita, et al.
Publicado: (2022)

Qualitative Aspects of Bone Marrow Adiposity in Osteoporosis
por: Pino, Ana María, et al.
Publicado: (2016)

HIF-1α Regulates Glucocorticoid-Induced Osteoporosis Through PDK1/AKT/mTOR Signaling Pathway
por: Xu, Wen-Ning, et al.
Publicado: (2020)

Four-Year Teriparatide Followed by Denosumab vs. Continuous Denosumab in Glucocorticoid-Induced Osteoporosis Patients With Prior Bisphosphonate Treatment
por: Hirooka, Yasuaki, et al.
Publicado: (2021)

Stress, Glucocorticoids and Bone: A Review From Mammals and Fish
por: Suarez-Bregua, Paula, et al.
Publicado: (2018)

Metformin and Bone Metabolism in Endogenous Glucocorticoid Excess: An Exploratory Study
por: Vogel, Frederick, et al.
Publicado: (2021)

Osteoporosis Therapy: Bone Modeling during Growth and Aging
por: Sugiyama, Toshihiro, et al.
Publicado: (2017)

Zuo-Gui-Wan Aqueous Extract Ameliorates Glucocorticoid-Induced Spinal Osteoporosis of Rats by Regulating let-7f and Autophagy
por: Shen, Gengyang, et al.
Publicado: (2022)

Glucocorticoid induced bone disorders in children: Research progress in treatment mechanisms
por: Hua, Junying, et al.
Publicado: (2023)

Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis
por: Koenen, Mascha, et al.
Publicado: (2018)

Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation
por: Liu, Peng, et al.
Publicado: (2016)

Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip
por: Zughaib, Marc T, et al.
Publicado: (2022)

Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
por: Hildebrandt, Susanne, et al.
Publicado: (2018)

Glucocorticoid Programing of the Mesopontine Cholinergic System
por: Borges, Sónia, et al.
Publicado: (2013)

Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
por: Yim, Hyung Joon, et al.
Publicado: (2020)

MR-Based Assessment of Bone Marrow Fat in Osteoporosis, Diabetes, and Obesity
por: Cordes, Christian, et al.
Publicado: (2016)

The Dibenzyl Isoquinoline Alkaloid Berbamine Ameliorates Osteoporosis by Inhibiting Bone Resorption
por: Zhang, Chongjing, et al.
Publicado: (2022)

Relationship between indices of circulating blood cells and bone homeostasis in osteoporosis
por: Li, Yuan, et al.
Publicado: (2022)

Deciphering core proteins of osteoporosis with iron accumulation by proteomics in human bone
por: Wang, Aifei, et al.
Publicado: (2022)

Opportunities and Challenges in Functional Genomics Research in Osteoporosis: Report From a Workshop Held by the Causes Working Group of the Osteoporosis and Bone Research Academy of the Royal Osteoporosis Society on October 5th 2020
por: Tobias, Jonathan H., et al.
Publicado: (2021)

Using Micro-CT Derived Bone Microarchitecture to Analyze Bone Stiffness – A Case Study on Osteoporosis Rat Bone
por: Wu, Yuchin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m7qu0ki1kdf3v3g2iq7m05580e